Registered Nurse in Park Ridge, NJ Accepting Medicare
3 Registered Nurse nurses found. Showing 1 - 3
 Sonal Desai, Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 2 Williams Crest, Park Ridge, NJ 07656 Phone: 551-252-8464 |
Ms. Laurel Marie Mengarelli, RN, CRNFA Registered Nurse - Registered Nurse First Assistant Medicare: Not Enrolled in Medicare Practice Location: 256 Bearwoods Rd, Park Ridge, NJ 07656 Phone: 201-825-1844 |
Ms. Diana Amelia Pree, RN, IBCLC Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 259 Capri Ter, Park Ridge, NJ 07656 Phone: 201-637-0625 |
News Archive
Study uses ethnically diverse sample to identify predictors of early substance use
Girls who were overweight as children are likely to begin using cigarettes, marijuana or alcohol at an earlier age than their healthy-weight peers, according to a new study by researchers in the Indiana University School of Education.
NextGen Healthcare becomes CCHIT Certified for Dermatology and Behavioral Health
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced that NextGen® Ambulatory EHR version 5.6, a CCHIT Certified® 2011 Ambulatory EHR, has been additionally certified for Dermatology and Behavioral Health in the Certification Commission for Health Information Technology's (CCHIT®) certification program.
New treatment for facial wrinkles combines high-intensity light and green tea extract lotion
Scientists in Germany are reporting a major improvement in their potential new treatment for facial wrinkles that could emerge as an alternative to Botox and cosmetic surgery. The non-invasive technique combines high-intensity light from light-emitting diodes (LEDs) and a lotion made of green tea extract. It works ten times faster than a similar anti-wrinkle treatment that uses LEDs alone, the researchers say.
Harbor BioSciences to receive patent for Apoptone in treatment of prostate cancer, breast cancer and benign prostatic hypertrophy
Harbor BioSciences, Inc. today announced that the company has received a notice of allowance from the United States Patent Office of patent claims covering the use of its lead product candidate Apoptone®. The patent claims cover the use of Apoptone to treat prostate cancer, breast cancer and benign prostatic hypertrophy. Apoptone (HE3235) is a novel synthetic steroid analog of a dihydrotestosterone metabolite and has been found to stimulate cell death (apoptosis) in animal models of prostate and breast cancers.
Many colorectal cancer survivors do not receive recommended follow-up screening
A new analysis reveals that fewer than half of older patients successfully treated for colorectal cancer receive the recommended screening schedule to detect any recurrence of cancer.
› Verified 6 days ago
Registered Nurse
Nurse Practitioner
Licensed Practical Nurse